Related Experiment Video
Updated: Feb 10, 2026

Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
Impaired Microcirculation in Children After Kidney Transplantation: Everolimus Versus Mycophenolate Based
Stephan Ruben1, Martin Kreuzer1, Anja Büscher2
1Dept. of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Hannover, Germany.
Insights
Everolimus-based immunosuppression in pediatric kidney transplant recipients (KTx) is linked to worse microvascular function compared to standard treatment. This suggests a higher risk of endothelial dysfunction in KTx patients on everolimus (EVR).
Area of Science:
- Pediatric Nephrology
- Transplantation Immunology
- Vascular Biology
Background:
- The impact of immunosuppressive regimens on vascular health in pediatric kidney transplant recipients (KTx) remains unclear.
- Assessing micro- and macro-vascular status is crucial for long-term outcomes in KTx patients.
Purpose of the Study:
- To investigate the association between everolimus (EVR)-based immunosuppression and vascular status in pediatric KTx recipients.
- To compare micro- and macro-vascular function in KTx patients on EVR versus standard immunosuppression.
Main Methods:
- A cross-sectional, case-control study involving 44 pediatric KTx patients.
- Vascular markers included carotid intima-media thickness (cIMT), pulse wave velocity (PWV), and skin microvascular blood flow (laser-Doppler-fluximetry).
- Serum levels of angiopoietins, FGF23, and soluble klotho were measured.
Main Results:
- EVR-treated patients showed significantly reduced skin microvascular function compared to standard treatment (p<0.001).
- Both groups exhibited similar hypertension and increased cIMT compared to healthy controls.
- PWV and soluble klotho levels were comparable between the EVR and standard treatment groups.
Conclusions:
- Everolimus-based immunosuppression is associated with impaired endothelial function in pediatric KTx patients.
- Endothelial dysfunction appears more prevalent in KTx recipients receiving EVR compared to standard immunosuppressive therapy.
Background/Aims:
Whether the immunosuppressive regimen is associated with micro- and macro-vascular status in pediatric kidney transplant recipients (KTx) is unknown.
Methods:
We performed a cross-sectional, case-control study in 44 pediatric KTx patients on either everolimus (EVR) plus calcineurin inhibitor or standard treatment, i.e. mycophenolate mofetil plus calcineurin inhibitor. Measurement of carotid intima-media thickness (cIMT) via ultrasound, central pulse wave velocity (PWV) by a cuff-based oscillometric technique, and skin microvascular blood flow during local heating via laser-Doppler-fluximetry (LDF) served as marker of subclinical vascular disease. Serum concentrations of angiopoietin-1 and -2, fibroblast-growth factor 23 (FGF23) and soluble klotho were measured.
Results:
EVR-treated patients exhibited a similar degree of hypertension, increased cIMT, elevated pro-inflammatory angiopoietin-2, and diminished endothelial survival factor angiopoietin-1 compared to healthy children but presented with a twofold more reduced skin micro-vascular function compared to standard treatment (each p< 0.001). By contrast, PWV and soluble klotho levels were normal in both groups.
Conclusion:
Endothelial dysfunction seems more frequent in KTx patients on EVR-based immunosuppressive regimen compared to standard immunosuppression.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Kidney Structure
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Dosage Regimen: Individualization

